Maravai Lifesciences Holdings Inc. (MRVI)
NASDAQ · Healthcare
Maravai Lifesciences Holdings Inc. Revenue 2020–2025
Maravai Lifesciences Holdings Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Maravai Lifesciences Holdings Inc. revenue for the quarter ending March 31, 2026 was 65.8 M, a 40.53% increase year-over-year.
- Maravai Lifesciences Holdings Inc. revenue for the twelve months ending March 31, 2026 was 204.7 M.
- Maravai Lifesciences Holdings Inc. annual revenue for 2025 was 185.7 M, a 28.34% decrease from 2024.
- Maravai Lifesciences Holdings Inc. annual revenue for 2024 was 259.2 M, a 10.30% decrease from 2023.
- Maravai Lifesciences Holdings Inc. annual revenue for 2023 was 288.9 M, a 67.28% decrease from 2022.
- Maravai Lifesciences Holdings Inc. annual revenue for 2022 was 883.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Maravai Lifesciences Holdings Inc. Market Cap — FAQ
Maravai Lifesciences Holdings Inc. (MRVI) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRVI's market cap history?
The chart and table above show Maravai Lifesciences Holdings Inc.'s market cap by year and by quarter, including the growth rate.